throbber
I
`
`Clin. exp lmmuno/. (19SS) 62,3i0..:.3!4.
`
`In vivo and in vitro effects of doxycycline on leucocyte
`membrane receptors
`
`A. NiESS, J. GLETTE, A. I. HALSTENSEN, S. SANDBERG & C. 0. SOLBERG
`Medical Department Band Laboratory of Clinical Biochemistry, Haukeland Hospital, University
`of Bergen, Norway
`
`(Accepted for publication 14 May 1985)
`
`SUMMARY
`
`Tetracyclines, particularly doxycycline, have adverse effects on granulocyte function in
`vitro. We have examined the effects of doxycycline on membrane receptors for IgG (Fcy·
`R) and C3b (C3b-R) on granulocytes and lymphocytes, as well as on the sheep erythrocyte
`receptor (E-R) on T lymphocytes. Acne patients given doxycycline orally had a lower
`percentage of Fcy-R positive granulocy.tes (57%) than before treatment (80%) or
`compared to healthy controls (81%). Following in vitro doxycycline incubation, normal
`granulocytes showed decreased levels of Fey-R positive cells. This effect was counteracted
`by the addition of magnesium during incubation. The deleterious effect of doxycycline on
`granulocyte functions may be due to decreased levels of Fcy-R bearing granulocytes.
`Doxycycline in vivo or in vitro had no significant effect on the proportion of C3b-R bearing
`granulocytes or lymphocytes or the T lymphocyte percentage. After in vitro irradiation
`with light at 340-380 nm, however, both granulocytes and lymphocytes preincubated with
`doxycycline showed up to 50% decrease in Fcy-R bearing cells, while control cells without
`doxycycline were unaffected.
`
`Keywords doxycycline Fe receptor C3b receptor
`
`leucocytes
`
`INTRODUCTION
`
`The effects of tetracyclines, and in particular doxycycline, on polymorphonuclear leucocyte (PMN)
`functions have been extensively studied. In vitro studies have shown that doxycycline has
`deleterious effects on PMN migration (Belsheim, Gnarpe & Lafberg, 1979; Glette et al., 1982),
`phagocytosis (Forsgren, Schmeling & Quie, 1974; Gnarpe & Leslie, 1974), chemiluminescence and
`glucose oxidation (Giette eta/., 1982). The results of some, but not all, in vivo studies also indicate a
`deleterious effect (Glette eta!., 1982). In addition, Forsgren & Gnarpe (1973) found doxycycline to
`inactivate the complement system and interfere with the bactericidal effect of serum. Little is known
`about the mechanisms underlying these various effects of doxycycline. In the present study
`doxycycline in vivo and in vitro is shown to depress rosette formation between PMNs and antibody-
`coated erythrocytes, thus implying interference with the receptor for the Fe portion of
`immunoglobulin G.
`
`MATERIALS AND METHODS
`
`Peripheral blood was obtained from eight patients with acne, and from 25 healthy controls. Samples
`from the patients were taken immediately before and I week after institution of200 mg doxycycline
`orally per day. PMNs and lymphocytes were separated as described by Talstad(l981). Briefly, 2 ml
`Correspondence: Dr A. Na:ss, Medical Department B, N-5016 Haukeland, Sykehus, Norway.
`
`310
`
`.---------------------~
`Dr. Reddy's Laboratories, Ltd., et al.
`v.
`Galderma Laboratories, Inc.
`IPR2015-__
`Exhibit 1031
`
`Exh. 1031
`
`

`
`Effects of doxycycline on leucocyte membrane receptors
`311
`of heparinized (18 u/ml) blood was mixed with 2 ml of phosphate-buffered saline (PBS) and
`carefully layered on top of a two-layer mixture of Ficoll (Pharmacia, Stockholm, Sweden) and
`Isopaque (Nyegaard & Co., Oslo, N orway) in a plastic tube. After centrifugation at 600 g for 30 min
`the PMNs and lymphocytes, forming separate layers, were harvested, washed three times in PBS
`and resuspended in PBS to a concentration of 4 x 106/ml.
`Rosette techniques. 'Active' E-rosette-forming ce/ls (active E-RFC) were enumerated by adding
`0·2 ml of 1% sheep erythrocytes (E) to 0·2 ml oflymphocyte suspension, centrifuging at 200 g for 5
`min, resuspending, and counting (Smith et al., 1975). The active E-RFC population is considered to
`represent the immunologically active T lymphocytes (Wybran & Fudenberg, 1973).
`E-rosette-forming cel/s (E-RFC) were determined as described previously (Nress & Nyland,
`1978). A lymphocyte suspension of0·2 ml was mixed with an equal volume of0·5 E, incubated for 5
`min at 37°C, centrifuged for 5 min at 200 g, and stored in ice water overnight before being counted.
`PMN suspensions did not form active E-RFC or E-RFC.
`EA-rosette-forming ce/ls (EA-RFC) were enumerated by an assay with ox E sensitized with I
`agglutinating unit of rabbit lgG antiborlies (A). By this technique the presence on the cell of
`receptors for the Fe portion oflgG (Fcy-R) is demonstrated (Hallberg, Gurner & Coombs, 1973).
`Lymphocytes or PMN were mixed with an equal volume (0·2 ml) of indicator cells, and incubated at
`room temperature for 20 min.
`EAC-rosette-forming cel/s (EAC-RFC) were determined using sheep E sensitized with rabbit
`lgM antiborlies (A). Humanserum absorbed with zymosan was used as the source of complement
`(C). A mixture of 0·2 ml of lymphocyte or PMN suspension and 0·2 ml of EAC was incubated at
`37°C for 20 min. Cells having receptors for the C3b fraction of complement (C3b-R) form rosettes
`by this method (Matre & T0nder, 1976).
`All rosette preparations were counted by the same person, at a magnification of x 600. A
`minimum of 200 cells were counted and those with four or more adhering E were counted as RFC.
`lncubation studies. Sampies of0·2 ml ofPMN or lymphocytes were incubated at 37°C for 30 min
`in PBS, or PBS with doxycycline at the concentration of 6·25, 12·5, 25, 50 and 100 J.tg/ml. After
`incubation, cells were washed three times in PBS, and resuspended to 4 x 106/ml. Rosette sturlies
`were then performed as described above. In an additional experiment, 4 mM of Mg2+ was added to
`incubation tubes containing 50 j.lg doxycycline/ml. Similar experiments using Ca2+ were abandoned
`because of excessive clumping of cells.
`Irradiation. Contaminating erythrocytes in the granulocyte suspension were first lysed with
`ammonium chloride (Weening, Roos & Loos, 1974). The cells were than resuspended in PBS, pH
`7 · 3, to a concentration of7 x 106 cells/ml. Granulocytes and lymphocytes were incubated for 15 min
`at 37°C in PBS or PBS with 10 J.tg/ml of doxycycline. Irradiation was carried out at 20°C in 10-mm
`diameter test tubes, using a photochemotherapy unit PUV A (H. Haldmann, D-722 Schwenningen,
`FRG) containing 14 fiuorescent tubes (F8T5/BL PUVA, Sylvania) in a bank. About 70% of the
`emission energy ofthese lamps is between 340 and 380 nm. The light intensity is 66 Wjm2 at sample
`Ievel as measured with a UDT model x 80 optometer equipped with a radiometric filter (United
`Detector Technology, lnc., Santa Monica, California, USA). After 30 min irradiation the cells were
`centrifuged, resuspended in PBS to a concentration of 4 x 106 cells/ml, and the EA-RFC testwas
`performed.
`Statistics. The statistical significance of the observed differences was established by Wilcoxon
`tests on unpaired and paired samples as appropriate.
`
`RESULTS
`The pre-treatment Ievels of Fcy-R and C3b-R bearing PMN or lymphocytes from acne patients
`were not significantly different from those of the controls (Table 1). During treatment, however,
`PMN Fcy-R percentages decreased to a mean of57% (P<0·05). Lymphocyte Fcy-R Ievels were not
`significantly affected, nor were the proportians ofT lymphocytes (E-RFC). The percentage of C3 b-
`R bearing cells did not differ from controls.
`Incubation of PMN in increasing concentrations of doxycycline resulted in a significant
`decrease in PMN Fcy-R bearing cell percentage (Fig. 1 ). The Ievels of Fcy-R bearing lymphocytes
`also decreased during incubation, but less markedly.
`
`Exh. 1031
`
`

`
`A. Nass et al.
`312
`Table 1. Effect of oral doxycycline treatment on leucocyte membrane receptors
`
`Receptor-bearing
`granulocytes (%)
`
`Receptor-bearing
`lymphocytes (%)
`
`No.
`
`Fcy
`
`C3b
`
`E active
`
`E
`
`Fcy
`
`C3b
`
`Acne patients before treatment
`Ance patients during treatment
`Controls
`
`8
`8
`25
`
`80±7
`57±30*
`81 ± 12
`
`69±28
`80±6
`74±17
`
`34±12
`39±13
`39± 12
`
`67±14 32±17
`61± 17 28±18
`66± 11 29±9
`
`38± 12
`43±9
`35± 12
`
`Results are mean values ± s.d.
`*P<0·05
`
`When PMN or lymphocytes were incubated in 50 f1g doxycyclinefml there was a significant
`decrease of Fcy-R bearing PMN which was counteracted when 4 mM Mg2+ was included in the
`medium (Table 2).
`Incubation in 50 flg doxycyclinefml with or without 4 mM Mg2+ had no significant effect on the
`Fcy-R bearing lymphocyte Ievels.
`After PUV A irradiation, granulocytes and lymphocytes preincubated in 10 flg doxycyclinefml
`showed a significant decrease in Fcy-R bearing cell percentage, which was not observed in cells not
`pre-incubated with doxycycline (Table 3).
`
`\
`~~= ~-----------0 • 100
`
`Doxycycfine concentrotion (14g/mll
`Fig. 1. Percentage of Fe receptor positive cells after incubation of granulocytes ( •) and 1ymphocytes ( o) in PBS
`with and without doxycycline. *=No incubation.
`
`Table 2. In vitro effect of doxycycline on leucocyte Fcy receptors
`
`Fcy receptor bearing
`
`Granulocytes (%) Lymphocytes (%)
`
`Incubation
`None
`PBS
`Doxycycline 50 Jtg/ml
`Doxycycline 50 Jtg/ml
`with 4 mmol Mg2+
`
`74±9
`65± 13*
`45± 16*t
`
`65± 13t
`
`44± 18
`39±14
`37± 10
`
`47± 16
`
`Resu1ts are mean of six experiments ± s.d.
`*P<0·01
`tP<0·01
`
`Exh. 1031
`
`

`
`Effects of doxycycline on leucocyte membrane receptors
`Table 3. Percentages of Fcy-R bearing cells before and after exposure to PUVA light
`
`Afterirradiation (30 min)
`
`Before irradiation Doxycycline+ Doxycycline-
`
`Granulocytes
`Lymphocytes
`
`57±8
`33±9
`
`30±10
`20±15
`
`64±17
`30±6
`
`Doxycycline+ after 15 min preincubation at 37°C in doxycycline
`(10 JLg/ml) in PBS.
`Doxycycline- after 15 min preincubation at 37°C in PBS without
`doxycycline.
`Results are mean±s.d. (five experiments).
`
`DISCUSSION
`
`Wehave shown that doxycycline in vitro or in vivo is associated with a decrease in the proportion of
`Fcy-R bearing PMN. Untreated acne patients had normal Ievels ofC3b-R and Fcy-R bearingcells,
`which is consistent with the findings of Rebora, Dallegri & Patrone (1979) of normal neutrophil
`functions in such patients. Previous studies by several authors have documented a deleterious effect
`oftetracyclines on several PMN functions (Belsheim et al., 1979; Forsgren et al., 1974; Glette et al.,
`1982). The Fcy-R is important in the process of phagocytosis (Kelmpner & Gallin, 1978), and
`interference with this receptor may explain the impaired capacity of doxycycline-incubated PMN to
`phagocytize (Forsgren et al., 1974). One would expect the effect of doxycycline on the Fcy-R ofthe
`PMN tobe paralleled by similar results regarding the lymphocyte Fcy-R. However, these receptors
`arenot necessarily identical, and Colombatti, Heumann & Moretta (1981) found PMN Fcy-R tobe
`resistant to very high concentrations ofpronase, in contrast to lymphocyte Fcy-R. The mechanism
`by which the Fcy-R Ievels are reduced by doxycycline is not clear, but the divalent cation chelating
`effect of the tetracyclines (Gnarpe & Leslie, 1974) may be of irnportance as the addition of 4 mM
`Mg2+ reversed the Fcy-R decrease caused by 50 Jlg/rnl of doxycycline.
`The decreased percentage of Fcy-R bearing cells after doxycycline incubation cornbined with
`PUV A irradiation (Table 3) suggests photo darnage to the cell rnernbrane as one possible
`rnechanism. This cornbined treatrnent reduced the Ievels of Fcy-R positive granulocytes to about
`one-half of the pre-treatrnent Ievels, whereas irradiation alone had no significant effect.
`Tetracyclines arepotent photosensitizers and patients taking tetracyclines often develop skin
`lesions when exposed to sunshine (Harber, Kochevar & Shalita, 1982). Which subcellular structures
`are darnaged during irradiation of granulocytes in the presence of doxycycline is not known, but
`both the photodarnage to the Fcy-R receptor and the photodarnage to granulocyte locornotion and
`phagocytosis (Sandberg et al., 1984) can be explained by deterioration of the plasma rnernbrane.
`Tetracyclines have also been shown to influence lyrnphocyte functions. Banck & Forsgren (1979)
`found low concentrations of doxycycline in vitro to have an inhibiting effect on the mitogenic
`responsesofT and B lyrnphocytes, as weil as on in vitro antibody production, and protein synthesis
`in unstirnulated lymphocytes. Mice treated with tetracycline have been shown to have a reduced
`capacity to rnount delayed-type hypersensitivity to sheep E (Thong & Ferrante, 1980). The present
`study has not, however, demonstrated any significant difference in the proportion ofFcy-R, C3b-R
`or E-R bearing lymphocytes during doxycycline treatment. Neither had our patients low
`proportions ofFcy-R bearing lymphocytes, as was found by Valmin, Halberg & Redström (1982) in
`patients with severe staphylococcal furunculosis. The essentially unchanged percentage of E-RFC
`during doxycycline treatment does not support the clairn of Pudifin et al. (1978) that tetracycline
`treatrnent causes an increase in lymphocytes bearing bothE-R and surface irnrnunoglobulins.
`
`Exh. 1031
`
`

`
`A. Nass et al.
`The technical assistance of Wenke Trovik is highly appreciated. Indicator cells were kindly provided by the
`Broegelmann Research Laboratory for Microbiology, and by the Department of Microbiology and
`Immunology, the Gade Institute. This work was supported by the Norwegian Research Council for Science and
`the Humanities.
`
`REFERENCES
`
`BANCK, G. & FORSGREN, A. (1979) Antibiotics and
`supression of lymphocyte function in vitro. Anti-
`microb. Agents Chemother. 16, 554.
`ßELSHEIM, J., GNARPE, H. & lßFBERG, J. (1979)
`Granulocyte function during prophylaxis with dox-
`ycycline. Scand. J. Infect. Dis. 11, 287.
`COLOMBATII, M., HEUMANN, D. & MORETIA, L.
`(1981) Distribution and properties of Fe receptors
`for IgG on different leukocyte populations in man.
`Clin. exp. Immunol. 46,453.
`FORSGREN, A. & GNARPE, H. (1973) Tetracycline
`interference with the bactericidal effect of serum,
`Nature, 244, 82.
`FORSGREN, A., SCHMELING, D. & QUIE, P.G. (1974)
`Effect of tetracycline on the phagocytic function of
`human leukocytes. J. Infect. Dis. 130,412.
`GLEITE, J., HALSTENSEN, A., SANDBERG, s., HOPEN,
`G., HELLUM, K.B. & SOLBERG, C.O. (1982) Effect of
`doxycycline and PUV A light on human polymor-
`phonuclear leukocyte function. In The lnjluence of
`Antibioticson the Host-Parasite Relationship(ed. by
`H. U. Eickenberg, H. Hahn & W. Opferkuch) p. 33,
`Springer-Verlag, Berlin, FRG.
`GNARPE, H. & LESLIE, D. (1974) Tetracyclines and
`host defence mechanisms. Doxycycline interference
`with phagocytosis of Escherichia coli. Microbios.
`lOA, 127.
`HALLBERG, T., GURNER, B.W. & COOMBS, R.R.A.
`(1973) Opsonic adherence of sensitized ox red cells
`to human lymphocytes as measured by rosette
`formation. Int. Archs. Al/ergy appl. Immuno/. 44,
`500.
`HARBER, L.C., KOCHEVAR, I.E. & SHALITA, A.R.
`( 1982) Mechanisms of photosensitization to drugs
`in humans. In The Science of Photobio/ogy ( ed. by J.
`D. Regan & J. A. Parrish) p. 323, Plenum, New
`York, USA.
`KLEMPNER, M.S. & GALLIN, J.l. (1978) Separation
`and functional characterization of human neutro-
`phil subpopulations. Blood, 51, 659.
`
`MATRE, R. & TeNDER, 0. (1976) Comp1ement recep-
`tors in human renal glomeruli. Scand. J. Immunol.
`5, 437.
`N~, A. & NYLAND, H. (1978) Multiple sclersosis. T
`lymphocytes in cerebrospinal fluid and blood. Eur.
`Neuro/. 17, 6l.
`PuDIFIN, D.J., DUURSMA, J., FORMO, R. & BRAIN, P.
`(1978) 'Double marker' lymphocytes in patients
`receiving tetracycline. C/in. exp. Immunol. 34, 143.
`REBORA, A., DALLEGRI, F. & PATRONE, F. (1979)
`Neutrophil functions in acne conglobata. Dermato-
`logica, 159, 217.
`SANDBERG, s., GLEITE, J., HOPEN, G. & SOLBERG,
`C.O. (1984) Doxycycline induced photodarnage to
`human neutrophils and tryptophan. Photochem.
`Photobio/. 39, 43.
`SMITH, R., KERMAN, R., EZDINLI, E. & STEFANI, S.
`(1975) A modified assay for the detection ofhuman
`adult active rosette forming lymphocytes. J. Immu-
`nol. Methods, 8, 175.
`TALSTAD, I. (1981) Simultaneous separation ofmono-
`cytes, lymphocytes and polymorphonuclear cells
`from the peripheral blood. International Society of
`Haematology, European and African Division. 6th
`Meeting, Athens.
`THONG, Y.H. & FERRANTE, A. (1980) Effect of
`tetracycline treatment on immunological responses
`in mice. Clin. exp. Immunol. 39, 728.
`VALMIN, K., HALLBERG, T. & HEDSTR0M, S.A. (1982)
`Recurrent staphylococcal furunculosis: Lympho-
`cyte subsets and plasma immunoglobulins. Scand.
`J. Infect. Dis. 14, 152.
`WEENING, R.S., Roos, D. & Loos, J.A. (1974) Oxygen
`consumption of phagocytizing cells in human leuk-
`ocyte and granulocytes preparations: a compara-
`tive study. J. Lab. Clin. Med. 83, 570.
`WYBRAN, J. & FUDENBERG, H.H. (1973) Thymus
`derived rosette-forming cells. New Eng/. J. Med.
`288, 1072.
`
`Exh. 1031

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket